Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,511 | -46,049 | -26,772 | -8,555 | -12,760 |
| Depreciation Amortization | 5,499 | 1,006 | 944 | 407 | 2,578 |
| Accounts receivable | 6,868 | -9,078 | -6,772 | 1,051 | -714 |
| Other Working Capital | 14,480 | 5,883 | -406 | -357 | 374 |
| Other Operating Activity | 8,999 | 14,703 | 14,289 | 17,893 | 8,583 |
| Operating Cash Flow | $-69,665 | $-33,535 | $-18,717 | $10,439 | $-1,939 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -296 | -93 | -102 | -33 |
| Net Acquisitions | N/A | -30,401 | -14,090 | N/A | N/A |
| Purchase Of Investment | -41,161 | -45,814 | -23,861 | -15,422 | N/A |
| Sale Of Investment | 25,000 | 59,121 | 1,325 | N/A | N/A |
| Other Investing Activity | -6,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-22,161 | $-17,390 | $-36,719 | $-15,524 | $-33 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,303 |
| Debt Issued | 60,072 | 43,687 | 14,073 | 78,135 | 781 |
| Debt Repayment | -43,131 | -18,100 | -1,322 | -38,097 | -227 |
| Common Stock Issued | 67,258 | 6,324 | 324 | 80,104 | N/A |
| Common Stock Repurchased | N/A | -3,447 | -4,723 | -2,814 | N/A |
| Other Financing Activity | -2,091 | 0 | 0 | -4,219 | -118 |
| Financing Cash Flow | $82,108 | $28,464 | $8,352 | $113,109 | $2,739 |
| Exchange Rate Effect | 454 | 44 | 204 | N/A | N/A |
| Beginning Cash Position | 43,049 | 65,466 | 112,346 | 4,322 | 3,555 |
| End Cash Position | 33,785 | 43,049 | 65,466 | 112,346 | 4,322 |
| Net Cash Flow | $-9,264 | $-22,417 | $-46,880 | $108,024 | $767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,665 | -33,535 | -18,717 | 10,439 | -1,939 |
| Capital Expenditure | N/A | -296 | -93 | -102 | -33 |
| Free Cash Flow | -69,665 | -33,831 | -18,810 | 10,337 | -1,972 |